| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/26/2008 | CN101151264A Crystalline form of a quinolinone-carboxamide compound |
| 03/26/2008 | CN101151036A Sucrase activity inhibitor, glucoamylase activity inhibitor and food and feed containing the same |
| 03/26/2008 | CN101148642A Probiotic/non-probiotic combinations |
| 03/26/2008 | CN101148638A Marrow-strengthening cold-dispersing nourishing wine |
| 03/26/2008 | CN101148452A Oral cavity articles, preparation method and application thereof |
| 03/26/2008 | CN101148451A Oral cavity medicament and oral cavity nursing article |
| 03/26/2008 | CN101148443A Medicine for treating and preventing oral disease |
| 03/26/2008 | CN101147815A HIV (individual) vaccine making machine |
| 03/26/2008 | CN101147799A Medicine for treating gastritis and gastrointestinal ulcer |
| 03/26/2008 | CN101147797A Traditional Chinese medicine for treating chronic gastritis, gastro-duodenal ulcer, not healed aged stomach disease in many years |
| 03/26/2008 | CN101147792A Method for preparing capsule for treating hepatitis B, clearing heat and antitoxic |
| 03/26/2008 | CN101147789A Pharmaceutical prescription for treating stomach disease |
| 03/26/2008 | CN101147786A Medicine for treating gastric ulcer and duodenal ulcer |
| 03/26/2008 | CN101147784A Traditional Chinese medicine composition for treating irritable bowel syndrome and its preparation method |
| 03/26/2008 | CN101147777A Pseudo-ginseng power generating preparation and production technology |
| 03/26/2008 | CN101147775A Medicine preparation for treating hepatopathy |
| 03/26/2008 | CN101147758A Medicine for treating stomach disease and replenishing calcium and its preparation method |
| 03/26/2008 | CN101147757A Traditional Chinese medicine for treating chronic hepatitis B and its preparation process |
| 03/26/2008 | CN101147755A Medicinal preparation for treating hepatitis B |
| 03/26/2008 | CN101147728A 6-methocy bideoxy bideoxy guanosine long circulating liposome preparation and preparing method |
| 03/26/2008 | CN101147724A Medicine or sanitary product containing licorice flavone extraction for oral cavity |
| 03/26/2008 | CN101147582A Secretion promoting cake and making technology thereof |
| 03/26/2008 | CN101147581A White Chinese sorghum nutritive powder and preparation method thereof |
| 03/26/2008 | CN100376679C Protease, gene therefor and use thereof |
| 03/26/2008 | CN100376598C Dog intravenous injection albumin, its preparing method and dog intravenous injection albumin preparation |
| 03/26/2008 | CN100376581C [1,4]diazocino [7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents |
| 03/26/2008 | CN100376575C [1,4]diazepino[6,7,1-ij]quinoline derivatives as anti psychotic and antiobesity agents |
| 03/26/2008 | CN100376573C 1,3-dihydroimidazole fused-ring compound |
| 03/26/2008 | CN100376571C 6-substituted pyrido-pyrimidines |
| 03/26/2008 | CN100376530C Vitamin D analogues |
| 03/26/2008 | CN100376282C Medicine for treating spleen-stomach disharmony and increasing appetite and fortifying spleen |
| 03/26/2008 | CN100376264C Medicinal tea for treating apopsychia |
| 03/26/2008 | CN100376242C 2-aryl-propionic acid and medicine composition containing same |
| 03/26/2008 | CN100376166C Healthcare tea and its preparation method |
| 03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
| 03/25/2008 | US7348431 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/25/2008 | US7348426 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 03/25/2008 | US7348400 α-conotoxin peptides with analgesic properties |
| 03/25/2008 | US7348341 Chemical compounds |
| 03/25/2008 | US7348339 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent |
| 03/25/2008 | US7348336 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348313 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis |
| 03/25/2008 | US7348162 Nucleotide sequences coding polypeptides for use in the treatment and prevention of hematopoietic disorders, osteoporosis, osteogenesis, paget's disease, periodontal disease, hypercalcemia, cancer, cachexia, and |
| 03/25/2008 | US7348148 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 03/25/2008 | US7348138 Diagnostic methods and kits for identifying individuals exposed to West Nile virus or other viruses including Flavivirus or Pestivirus |
| 03/25/2008 | US7348017 such as 2-[Benzyl[(4-methoxyphenyl)sulfonyl]amino]-N-(3-thioxo-3H-1,2,4-dithiazol-5-yl)acetoamide; cosmetics; antiaging agents |
| 03/25/2008 | CA2371178C Prucalopride oral solution |
| 03/25/2008 | CA2370446C Pharmaceutical compounds |
| 03/25/2008 | CA2359987C 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 03/25/2008 | CA2291796C Therapeutically active compositions |
| 03/25/2008 | CA2264822C Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 03/25/2008 | CA2228281C Use of l-carnitine and acyl l-carnitines for lowering ceramide levels |
| 03/25/2008 | CA2174707C Chromone derivatives as nk1 and substance p antagonists |
| 03/20/2008 | WO2008034008A2 Kinase inhibitors useful for the treatment of proliferative diseases |
| 03/20/2008 | WO2008033999A2 Kinase inhibitors useful for the treatment of proliferative diseases |
| 03/20/2008 | WO2008033328A2 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders |
| 03/20/2008 | WO2008033142A1 Bile preparations for colorectal disorders |
| 03/20/2008 | WO2008032777A1 Antibacterial peptide and use thereof |
| 03/20/2008 | WO2008032764A1 Fused heterocyclic derivative |
| 03/20/2008 | WO2008032726A1 Solid pharmaceutical composition for oral administration comprising optically stable ramosetron |
| 03/20/2008 | WO2008032678A1 Adhesive preparation |
| 03/20/2008 | WO2008032450A1 Prophylactic and/or therapeutic agent for fatty liver |
| 03/20/2008 | WO2008031735A1 Pyridine- and quinoline-pyrimidine-derivatives |
| 03/20/2008 | WO2008031322A1 Application of acetylcholine esterase inhibitor medication of leonurus extractive as cholinomimetic |
| 03/20/2008 | WO2008017466A8 Pharmaceutically active tetrahydroisoquinoline-substituted benzimidazole derivatives |
| 03/20/2008 | WO2008003667A3 Combinations of monoamine reuptake inhibitors and potassium channel activators |
| 03/20/2008 | WO2007146341A9 Amorphous and crystalline forms of pantoprazole magnesium salt |
| 03/20/2008 | WO2007068462A3 Mtor inhibitors for the treatment of inflammatory bowel disease |
| 03/20/2008 | WO2007064755A3 Treatment of xerostomia with a sulfur-containing antioxidant |
| 03/20/2008 | US20080071233 Pharmaceutical compositions |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070979 13,14-dihydro-15-keto-16,16-difluoro-18(S)-methyl-prostaglandin (PGE1); decrease mucosal damage induced by acid, pepsin, nonsteroidal antiinflammatory drugs, and bacterial infection from epithelial surfaces; antiinflammatory agent, microbiocide |
| 03/20/2008 | US20080070964 Opioid receptor active compounds |
| 03/20/2008 | US20080070947 Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 03/20/2008 | US20080070923 3-isopropyl-2-oxo-2,3-dihydrobenzoimidazole-1-carboxylic acid [8-((S)-2-hydroxy-3-methylamino-propyl)-8-azabicyclo[3.2.1]oct-3-yl]-amide; 5-HT4 receptor agonist; bioavailability upon oral administration; treating a disorder of reduced motility of the gastrointestinal tract |
| 03/20/2008 | US20080070903 New pyrimidine derivatives and new pyridine derivatives |
| 03/20/2008 | US20080070901 Cholineterase inhibitors for treating inflammation |
| 03/20/2008 | US20080070890 Spirocyclic Azetidinone Compounds and Methods of Use Thereof |
| 03/20/2008 | US20080070871 N-Phenylphosphoric Acid Triamides, Method for the Production Thereof and Their Use as Agents for Regulating or Inhibiting Enzymatic Urea Hydrolysis |
| 03/20/2008 | US20080070259 Using presence or absence of mutation in metalloenzyme polynucleotides as diagnostic indicator of cardiovascular and neurodegenerative disorders |
| 03/20/2008 | US20080069861 Gastrointestinal health |
| 03/20/2008 | US20080069846 Gene coding, gene expression, purification; used as detergents, cosmetics, leather processing, softening for food, meats, animal feeds |
| 03/20/2008 | US20080069841 Pharmaceutical Compositions Containing Botulinum Neurotoxin A2 |
| 03/20/2008 | DE69717831C5 Substituierte 2-(2,6-dioxopiperidin-3-yl)-phthalimide und -1-oxoisoindoline und verfahren zur reduzierung des tnf-alpha-spiegels Substituted 2- (2,6-dioxopiperidin-3-yl) -1-oxoisoindoline and -phthalimides and method for reducing the TNF-alpha levels |
| 03/20/2008 | CA2662938A1 Light-stable solid pharmaceutical composition of ramosetron |
| 03/20/2008 | CA2662897A1 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders |
| 03/20/2008 | CA2662099A1 Pyridine- and quinoline-pyrimidine-derivatives |
| 03/19/2008 | EP1901071A1 Methods of diagnosing, preventing and treating infection with hepatitis c virus |
| 03/19/2008 | EP1900815A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 03/19/2008 | EP1900728A1 Pharmaceutical composition comprising pyrazolone derivative |
| 03/19/2008 | EP1900360A1 Homer a new target of treating psychiatric disorders |
| 03/19/2008 | EP1899341A1 Spiro-imidaznaphthyridine derivatives as gastric acid secretion inhibitors |
| 03/19/2008 | EP1899338A1 Spiro-benzimidazoles as inhibitors of gastric acid secretion |
| 03/19/2008 | EP1899326A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 03/19/2008 | EP1899324A2 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
| 03/19/2008 | EP1899318A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 03/19/2008 | EP1898712A2 Fortified cereal bran to promote digestive health |
| 03/19/2008 | EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |